1980
DOI: 10.1111/j.1525-1594.1980.tb03893.x
|View full text |Cite
|
Sign up to set email alerts
|

Long‐Term Clinical and Hemodynamic Evaluation of the Ionescu‐Shiley Pericardial Xenograft Heart Valve

Abstract: Pericardial xenograft heart valves have been used in 469 patients for single or multiple valve replacement. Early in the series, valves were made in-house, but since May 1976, valves have been made by Shiley Laboratories, Inc. During the eight-year observation period, there were 7% early and 7.9% late deaths. Although no anti-coagulants were used on a long-term basis, there were only eight mild embolic episodes. Preoperatively, 56--98% of all patients were in class III or IV of the NYHA classification; postope… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
9
0

Year Published

1983
1983
1987
1987

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 12 publications
0
9
0
Order By: Relevance
“…A similarly low degradation rate was found in glutaraldehyde-treated pericardial xenografts (36), and promising results are also reported for glyceroltreated dura mater allografts (74).…”
mentioning
confidence: 78%
See 4 more Smart Citations
“…A similarly low degradation rate was found in glutaraldehyde-treated pericardial xenografts (36), and promising results are also reported for glyceroltreated dura mater allografts (74).…”
mentioning
confidence: 78%
“…None of the mitral valve prostheses are free of gradients at rest, indicating that conversion of the naturally expansible mitral annulus into a fixed diameter orifice (71) and/or a variable resistance to valve opening (inertia of occluder, stiffness of leaflets) may play a role. During exercise mitral valve gradients increase in all prostheses, the older disc valves (34,35,58,59,72) showing distinctly higher differentials than the Starr-Edwards ball (39), the Björk-Shiley (12,50), the Lillehei-Kaster (30,34,35,50), and the stented homografts (29,35) and xenografts (31,36). No significant differences can be noted among the bioprostheses, perhaps with the exception of slightly higher gradients in the pericardial xenografts (36).…”
Section: Jones 1978mentioning
confidence: 92%
See 3 more Smart Citations